|
Progress Report Tools and Resources |
|
|
|
|
|
|
|
|
|
Summary Table: Treatment – Bladder, Breast, Colorectal
|
|
Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found in the report.
Trend key: |
|
green - headed in the right direction |
|
|
red - headed in the wrong direction |
|
|
black - stable or non-significant change (NSC) |
|
|
blue - Healthy People 2020 target |
|
Bladder cancer treatment 1995–2003 |
Breast cancer treatment: Breast-conserving surgery and radiation 1992–2008 |
Breast cancer treatment: Multi-agent chemotherapy 1987–2005 |
Colorectal cancer treatment 1987–2005 |
Measure |
Percentage of individuals receiving intravesical therapy in non-muscle invasive bladder cancer. |
Percentage of women aged 20 years and older, diagnosed with early-stage breast cancer (less than stage IIIA), receiving breast-conserving surgery and radiation treatment. |
Percentage of women aged 20 years and older, diagnosed with node positive, stage I–IIIa breast cancer, receiving multi-agent chemotherapy. |
Percentage of individuals ages 20 years and older, who were diagnosed with stage III colon cancer and received chemotherapy, or were diagnosed with stage II or stage III rectal cancer and received chemotherapy with or without radiotherapy. |
Recent summary trend* |
Rising 1995–2003 |
Falling 2004–2008 |
Rising 2001–2005 |
Rising 2001–2005 |
Desired direction |
Rising |
Rising |
Rising |
Rising |
Trend |
Rising
|
Non-significant change, then falling, then non-significant change, then falling
|
Rising
|
Rising
|
Most recent estimate |
In 2003, 27 percent of patients with non-muscle invasive disease received intravesical therapy. New estimates will be available in 2013. |
In 2008, 35 percent of women ages 20 years and older diagnosed with early-stage breast cancer (less than stage IIIA) received mastectomy, 41 percent received breast-conserving surgery plus radiation, and 19 percent received breast-conserving surgery only. |
In 2005, 67 percent of women aged 20 years and older, diagnosed with node positive breast cancer, received multi-agent chemotherapy. |
In 2005, 60 percent of stage III colon and stage II and III rectal patients aged 65 years and older received adjuvant chemotherapy, while more than 85 percent of patients aged 20 to 64 received chemotherapy. A colorectal patterns of care study is currently being conducted for diagnosis year 2010. |
Healthy People 2020 target |
There are no Healthy People 2020 targets for cancer treatment, including bladder cancer treatment. |
There are no Healthy People 2020 targets for cancer treatment, including breast cancer treatment. |
There are no Healthy People 2020 targets for cancer treatment, including breast cancer treatment. |
There are no Healthy People 2020 targets for cancer treatment, including colorectal cancer treatment. |
More information |
Bladder Cancer Treatment |
Breast Cancer Treatment |
Colorectal Cancer Treatment |
|